{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:32:28Z","timestamp":1791307948820,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T00:00:00Z","timestamp":1354579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T00:00:00Z","timestamp":1354579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/leu.2012.351","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T07:41:43Z","timestamp":1354606903000},"page":"1080-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Contributions of the RhoGEF activity of p210 BCR\/ABL to disease progression"],"prefix":"10.1038","volume":"27","author":[{"given":"I","family":"Tala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I P","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,4]]},"reference":[{"key":"BFleu2012351_CR1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood.V88.7.2375.bloodjournal8872375","volume":"88","author":"JV Melo","year":"1996","unstructured":"Melo JV . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375\u20132384.","journal-title":"Blood"},{"key":"BFleu2012351_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330\u20131340.","journal-title":"N Engl J Med"},{"key":"BFleu2012351_CR3","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","volume":"88","author":"F Pane","year":"1996","unstructured":"Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction). Blood 1996; 88: 2410\u20132414.","journal-title":"Blood"},{"key":"BFleu2012351_CR4","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1128\/MCB.11.4.1785","volume":"11","author":"AJ Muller","year":"1991","unstructured":"Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR et al. BCR first exon sequences specifically activate the BCR\/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 1991; 11: 1785\u20131792.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012351_CR5","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1128\/MCB.13.12.7587","volume":"13","author":"JR McWhirter","year":"1993","unstructured":"McWhirter JR, Galasso DL, Wang JY . A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins. Mol Cell Biol 1993; 13: 7587\u20137595.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012351_CR6","doi-asserted-by":"publisher","first-page":"15353","DOI":"10.1074\/jbc.271.26.15353","volume":"271","author":"Y Maru","year":"1996","unstructured":"Maru Y, Afar DE, Witte ON, Shibuya M . The dimerization property of glutathione S-transferase partially reactivates Bcr-Abl lacking the oligomerization domain. J Biol Chem 1996; 271: 15353\u201315357.","journal-title":"J Biol Chem"},{"key":"BFleu2012351_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","volume":"75","author":"AM Pendergast","year":"1993","unstructured":"Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175\u2013185.","journal-title":"Cell"},{"key":"BFleu2012351_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0092-8674(91)90148-R","volume":"66","author":"AM Pendergast","year":"1991","unstructured":"Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON . BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 1991; 66: 161\u2013171.","journal-title":"Cell"},{"key":"BFleu2012351_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/leu.2009.196","volume":"24","author":"S Demehri","year":"2009","unstructured":"Demehri S, O'Hare T, Eide CA, Smith CA, Tyner JW, Druker BJ et al. The function of the pleckstrin homology domain in BCR-ABL-mediated leukemogenesis. Leukemia 2009; 24: 226\u2013229.","journal-title":"Leukemia"},{"key":"BFleu2012351_CR10","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA . The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399\u20131412.","journal-title":"J Exp Med"},{"key":"BFleu2012351_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.2408149","volume":"247","author":"TG Lugo","year":"1990","unstructured":"Lugo TG, Pendergast AM, Muller AJ, Witte ON . Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990; 247: 1079\u20131082.","journal-title":"Science"},{"key":"BFleu2012351_CR12","first-page":"F1","volume":"1332","author":"IP Whitehead","year":"1997","unstructured":"Whitehead IP, Campbell S, Rossman KL, Der CJ . Dbl family proteins. Biochim Biophys Acta 1997; 1332: F1\u201323.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu2012351_CR13","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/sj.onc.1210933","volume":"27","author":"T Daubon","year":"2008","unstructured":"Daubon T, Chasseriau J, Ali AE, Rivet J, Kitzis A, Constantin B et al. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs. Oncogene 2008; 27: 2673\u20132685.","journal-title":"Oncogene"},{"key":"BFleu2012351_CR14","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/sj.onc.1210841","volume":"27","author":"S Sahay","year":"2008","unstructured":"Sahay S, Pannucci NL, Mahon GM, Rodriguez PL, Megjugorac NJ, Kostenko EV et al. The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation. Oncogene 2008; 27: 2064\u20132071.","journal-title":"Oncogene"},{"key":"BFleu2012351_CR15","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/sj.onc.1206626","volume":"22","author":"T Harnois","year":"2003","unstructured":"Harnois T, Constantin B, Rioux A, Grenioux E, Kitzis A, Bourmeyster N . Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl. Oncogene 2003; 22: 6445\u20136454.","journal-title":"Oncogene"},{"key":"BFleu2012351_CR16","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1128\/MCB.11.9.4710","volume":"11","author":"M Kelliher","year":"1991","unstructured":"Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N . Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR\/ABL oncogene. Mol Cell Biol 1991; 11: 4710\u20134716.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012351_CR17","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFleu2012351_CR18","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1158\/0008-5472.CAN-06-0536","volume":"66","author":"OO Olabisi","year":"2006","unstructured":"Olabisi OO, Mahon GM, Kostenko EV, Liu Z, Ozer HL, Whitehead IP . Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Res 2006; 66: 6250\u20136257.","journal-title":"Cancer Res"},{"key":"BFleu2012351_CR19","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1038\/sj.onc.1205678","volume":"21","author":"M Korus","year":"2002","unstructured":"Korus M, Mahon GM, Cheng L, Whitehead IP . p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr. Oncogene 2002; 21: 4601\u20134612.","journal-title":"Oncogene"},{"key":"BFleu2012351_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ccr.2007.10.015","volume":"12","author":"EK Thomas","year":"2007","unstructured":"Thomas EK, Cancelas JA, Chae HD, Cox AD, Keller PJ, Perrotti D et al. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 2007; 12: 467\u2013478.","journal-title":"Cancer Cell"},{"key":"BFleu2012351_CR21","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nm0896-876","volume":"2","author":"H Hanenberg","year":"1996","unstructured":"Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA . Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 1996; 2: 876\u2013882.","journal-title":"Nat Med"},{"key":"BFleu2012351_CR22","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829.422k14_3829_3840","volume":"92","author":"X Zhang","year":"1998","unstructured":"Zhang X, Ren R . Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998; 92: 3829\u20133840.","journal-title":"Blood"},{"key":"BFleu2012351_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/107327480901600202","volume":"16","author":"LA Hazlehurst","year":"2009","unstructured":"Hazlehurst LA, Bewry NN, Nair RR, Pinilla-Ibarz J . Signaling networks associated with BCR-ABL-dependent transformation. Cancer Control 2009; 16: 100\u2013107.","journal-title":"Cancer Control"},{"key":"BFleu2012351_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","volume":"1","author":"M Sattler","year":"2002","unstructured":"Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K et al. Critical role for Gab2 in transformation by BCR\/ABL. Cancer Cell 2002; 1: 479\u2013492.","journal-title":"Cancer Cell"},{"key":"BFleu2012351_CR25","first-page":"839","volume":"12","author":"M Sattler","year":"1996","unstructured":"Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\/ABL and p210BCR\/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 1996; 12: 839\u2013846.","journal-title":"Oncogene"},{"key":"BFleu2012351_CR26","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V96.6.2269","volume":"96","author":"F Gesbert","year":"2000","unstructured":"Gesbert F, Griffin JD . Bcr\/Abl activates transcription of the Bcl-X gene through STAT5. Blood 2000; 96: 2269\u20132276.","journal-title":"Blood"},{"key":"BFleu2012351_CR27","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V95.6.2118","volume":"95","author":"C Sillaber","year":"2000","unstructured":"Sillaber C, Gesbert F, Frank DA, Sattler M, Griffin JD . STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells. Blood 2000; 95: 2118\u20132125.","journal-title":"Blood"},{"key":"BFleu2012351_CR28","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1074\/jbc.M309525200","volume":"279","author":"ED Gallagher","year":"2004","unstructured":"Gallagher ED, Gutowski S, Sternweis PC, Cobb MH . RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 2004; 279: 1872\u20131877.","journal-title":"J Biol Chem"},{"key":"BFleu2012351_CR29","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1523\/JNEUROSCI.0295-04.2004","volume":"24","author":"K Kobayashi","year":"2004","unstructured":"Kobayashi K, Takahashi M, Matsushita N, Miyazaki J, Koike M, Yaginuma H et al. Survival of developing motor neurons mediated by Rho GTPase signaling pathway through Rho-kinase. J Neurosci 2004; 24: 3480\u20133488.","journal-title":"J Neurosci"},{"key":"BFleu2012351_CR30","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jcb.22059","volume":"106","author":"T Yoshida","year":"2009","unstructured":"Yoshida T, Clark MF, Stern PH . The small GTPase RhoA is crucial for MC3T3-E1 osteoblastic cell survival. J Cell Biochem 2009; 106: 896\u2013902.","journal-title":"J Cell Biochem"},{"key":"BFleu2012351_CR31","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.onc.1210790","volume":"27","author":"S Zhu","year":"2008","unstructured":"Zhu S, Korzh V, Gong Z, Low BC . RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek\/Erk pathway. Oncogene 2008; 27: 1580\u20131589.","journal-title":"Oncogene"},{"issue":"3","key":"BFleu2012351_CR32","doi-asserted-by":"publisher","first-page":"e33773","DOI":"10.1371\/journal.pone.0033773","volume":"7","author":"Shuangmin Zhang","year":"2012","unstructured":"Zhang S, Zhou X, Lang RA, Guo F . RhoA of the Rho family small GTPases is essential for B lymphocyte development. PloS one 7: e33773.","journal-title":"PLoS ONE"},{"key":"BFleu2012351_CR33","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/sj.leu.2404762","volume":"21","author":"J Burthem","year":"2007","unstructured":"Burthem J, Rees-Unwin K, Mottram R, Adams J, Lucas GS, Spooncer E et al. The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells. Leukemia 2007; 21: 1708\u20131714.","journal-title":"Leukemia"},{"key":"BFleu2012351_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.leukres.2006.05.021","volume":"31","author":"F Pompetti","year":"2007","unstructured":"Pompetti F, Spadano A, Sau A, Mennucci A, Russo R, Catinella V et al. Long-term remission in BCR\/ABL-positive AML-M6 patient treated with Imatinib Mesylate. Leuk Res 2007; 31: 563\u2013567.","journal-title":"Leuk Res"},{"key":"BFleu2012351_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1309\/B4NVER1AJJ84CTUU","volume":"127","author":"CP Soupir","year":"2007","unstructured":"Soupir CP, Vergilio JA, Dal Cin P, Muzikansky A, Kantarjian H, Jones D et al. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 2007; 127: 642\u2013650.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2012351_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood.V75.1.317.317","volume":"75","author":"GJ Morgan","year":"1990","unstructured":"Morgan GJ, Wiedemann LM, Chan LC, Price CM, Kanfer EJ, Galton DA . A case of M-BCR-rearranged, Philadelphia-positive AML that relapsed as chronic phase CML. Blood 1990; 75: 317\u2013318.","journal-title":"Blood"},{"key":"BFleu2012351_CR37","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.V72.5.1829.1829","volume":"72","author":"CM Price","year":"1988","unstructured":"Price CM, Rassool F, Shivji MK, Gow J, Tew CJ, Haworth C et al. Rearrangement of the breakpoint cluster region and expression of P210 BCR-ABL in a \"masked\" Philadelphia chromosome-positive acute myeloid leukemia. Blood 1988; 72: 1829\u20131832.","journal-title":"Blood"},{"key":"BFleu2012351_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MPH.0b013e3181983c88","volume":"31","author":"P Sharma","year":"2009","unstructured":"Sharma P, Dhingra KK, Roy S, Singh T . An acute myeloid leukemia M6b blast crisis with giant proerythroblasts in chronic myeloid leukemia. J Pediatr Hematol Oncol 2009; 31: 220\u2013221.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012351","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:36:54Z","timestamp":1648741014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,4]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFleu2012351"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.351","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,4]]},"assertion":[{"value":"26 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}